- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 2 Diabetes With Diabetic Macular Edema in Ireland
Total 350 results
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada
-
PfizerCompletedDiabetes Mellitus, Type 2Canada, United States, Korea, Republic of, Puerto Rico
-
BayerCompletedDiabetic Foot | Ulcer | Abscess | Wound InfectionItaly, Spain, Greece, Ireland, Russian Federation, United Kingdom, Germany, Austria, Belgium, France, Hungary, South Africa, Romania, Bulgaria, Poland, Israel, Latvia, Ukraine, Lithuania, Netherlands
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Taiwan, Philippines, Australia, Hong Kong, Korea, Republic of, Canada, Italy, Malaysia, United Kingdom, Mexico, Greece, Spain, Netherlands, Switzerland, Israel, Portugal, Germany, Finland, Norway, Romania, Sweden, Serbia and more
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Colombia, Mexico, Portugal, Bulgaria, India, Malaysia, Turkey, Ukraine, Greece, Sweden, Singapore, Czech Republic, Argentina, Puerto Rico, Russian Federation, Thailand, Slovakia, Latvia, Estonia, Peru
-
GlaxoSmithKlineCompletedNon-Insulin-Dependent Diabetes MellitusSpain, Germany, Belgium, United Kingdom, Ireland, Netherlands, Italy, France, Mexico, Switzerland, Lithuania
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Argentina, Canada, Peru, Australia, Latvia, Costa Rica, Russian Federation, New Zealand, Colombia, Mexico, Czech Republic, Ecuador
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Peru, Israel, Australia, United Kingdom, Korea, Republic of, Spain, Philippines
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Canada, France, Poland, Germany, Israel, India, Ukraine, Korea, Republic of, Malaysia, Netherlands, New Zealand, Singapore, Brazil, Austria, Denmark, Belgium
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Belgium, Canada, China, Croatia, Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, R... and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Germany, Estonia, Russian Federation, South Africa, India, Ukraine, Mexico, Greece, New Zealand, Poland, Czechia, Lithuania, Romania, Puerto Rico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Belgium, Denmark, Spain, Ireland, Netherlands, United Kingdom, Hungary, Italy, France, Austria, Czechia, Norway, Finland, Sweden
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Russian Federation, United States, Spain, Italy, Puerto Rico, Canada, Poland, Austria, Hungary, Israel, Greece, Taiwan, Argentina, Romania, Mexico, Slovakia
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Mexico, South Africa
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Russian Federation, United Kingdom, South Africa
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Mexico, Peru, Russian Federation, United Kingdom, Philippines, South Africa, Spain, Hong Kong, Albania
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, United Kingdom, Korea, Republic of, Peru, South Africa, India
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Spain, United Kingdom, India, Philippines, Russian Federation, Hong Kong
-
Duke UniversityThe Miriam HospitalRecruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
-
Novo Nordisk A/SActive, not recruitingObesity | Diabetes Mellitus, Type 2United States, Canada, Hungary, Portugal, Slovakia, South Africa, Poland, Bulgaria
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedDiabetes Mellitus, Type 2 | Erectile DysfunctionUnited States, Canada
-
Eli Lilly and CompanyCompletedCardiovascular Disease | Diabetes Mellitus, Type 2Argentina, Canada, Germany, Spain, United Kingdom, United States, Hungary, Puerto Rico, Bulgaria, Poland, Korea, Republic of, Australia, Brazil, Mexico, Chile, Colombia, Czechia, Latvia, Lithuania, New Zealand, Romania, Russian Federation and more
-
Temple UniversityUniversity of PennsylvaniaUnknownObstructive Sleep Apnea | Type 2 DiabetesUnited States
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
Andromeda Biotech Ltd.CompletedType 1 Diabetes MellitusUnited States, Russian Federation, Israel, Spain, Lithuania, Germany, Austria, Belarus, Canada, Czech Republic, Finland, Hungary, Italy, Poland
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Hungary, Brazil, Slovakia
-
Medtronic DiabetesCompletedType 1 Diabetes MellitusUnited States
-
Rhode Island HospitalCystic Fibrosis FoundationRecruitingCystic Fibrosis | Cystic Fibrosis-related Diabetes | Cystic Fibrosis With Intestinal ManifestationsUnited States
-
ProkidneyPPD; Iqvia Pty LtdActive, not recruitingChronic Kidney Diseases | Type 2 Diabetes MellitusUnited States, United Kingdom, Taiwan, Australia, Canada
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedDiabetes Mellitus, Type 2 | Dyslipidemia | Peripheral Vascular Disease | Coronary Arteriosclerosis | Cerebrovascular AccidentGreece, Ireland, Russian Federation, Slovakia, Poland, Hungary, Portugal, Switzerland
-
Eli Lilly and CompanyRecruitingObesity | Overweight | Obstructive Sleep Apnea | Type 2 DiabetesAustralia, United States, Mexico, Spain, India, Brazil, Romania, Taiwan, Argentina
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States, Germany, Argentina, Belgium, Brazil, Canada, Chile, Colombia, France, Italy, Korea, Republic of, Luxembourg, Mexico, Netherlands, Russian Federation, Saudi Arabia, Singapore, Slovenia, Spain, Switzerland, Taiwan, Th... and more
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Spain, United Kingdom, Czechia, Hungary, Thailand, Turkey, Vietnam, Korea, Republic of, Brazil, Peru, Philippines, Poland, China, Japan, Taiwan, Hong... and more
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
Marjukka KolehmainenLund University; Uppsala University; Aarhus University Hospital; University of... and other collaboratorsCompletedCardiovascular Diseases | Insulin Resistance | Type 2 Diabetes | Impaired Glucose Tolerance | Abdominal ObesitySweden, Denmark, Finland, Iceland, Norway
-
Eli Lilly and CompanyActive, not recruitingDiabetes | Type 1 DiabetesUnited States, Taiwan, Poland, Argentina, Japan, Slovakia, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, Denmark, Sweden, Netherlands, Belgium, Finland, Macedonia, The Former Yugoslav Republic of, Norway, Israel, Spain, Croatia, Slovenia, United Kingdom, Switzerland, Ireland
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Israel, Taiwan, Australia, Russian Federation, United Kingdom, Korea, Republic of, Spain, Brazil, Colombia, India, Philippines, South Africa
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Germany, Argentina, Czechia, Greece, Slovakia
-
St Vincent's University Hospital, IrelandUniversity College Dublin; The Heartbeat Trust; Crofton Cardiac Centre, DublinCompletedMyocardial Infarction | Hypertension | Obesity | Diabetes | Left Ventricular DysfunctionIreland
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Hong Kong, Israel, New Zealand, Ukraine